These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats. Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652 [TBL] [Abstract][Full Text] [Related]
25. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR. Martín-Garrido A; González-Ramos M; Griera M; Guijarro B; Cannata-Andia J; Rodriguez-Puyol D; Rodriguez-Puyol M; Saura M Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):567-73. PubMed ID: 21164076 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling. Zhang B; Alruwaili N; Kandhi S; Deng W; Huang A; Wolin MS; Sun D PLoS One; 2018; 13(7):e0200307. PubMed ID: 29985945 [TBL] [Abstract][Full Text] [Related]
28. Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle cells. Guo Y; Xu C; Man AWC; Bai B; Luo C; Huang Y; Xu A; Vanhoutte PM; Wang Y Cardiovasc Res; 2019 Mar; 115(3):678-690. PubMed ID: 30165439 [TBL] [Abstract][Full Text] [Related]
29. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta. Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857 [TBL] [Abstract][Full Text] [Related]
30. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta. El-Awady MS; Smirnov SV; Watson ML Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822 [TBL] [Abstract][Full Text] [Related]
31. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences. Ruiz-Torres MP; Griera M; Chamorro A; Díez-Marqués ML; Rodríguez-Puyol D; Rodríguez-Puyol M Cardiovasc Res; 2009 Apr; 82(1):125-32. PubMed ID: 19126601 [TBL] [Abstract][Full Text] [Related]
32. Sodium nitrite causes relaxation of the isolated rat aorta: By stimulating both endothelial NO synthase and activating soluble guanylyl cyclase in vascular smooth muscle. Ling WC; Lau YS; Murugan DD; Vanhoutte PM; Mustafa MR Vascul Pharmacol; 2015 Nov; 74():87-92. PubMed ID: 26044183 [TBL] [Abstract][Full Text] [Related]
34. A primer for measuring cGMP signaling and cGMP-mediated vascular relaxation. Straub AC; Beuve A Nitric Oxide; 2021 Dec; 117():40-45. PubMed ID: 34601102 [TBL] [Abstract][Full Text] [Related]
35. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells. Kostic TS; Andric SA; Stojilkovic SS Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997 [TBL] [Abstract][Full Text] [Related]
36. The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective. Krishnan SM; Kraehling JR; Eitner F; Bénardeau A; Sandner P Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890734 [TBL] [Abstract][Full Text] [Related]
37. High salt intake impairs vascular nitric oxide/cyclic guanosine monophosphate system in spontaneously hypertensive rats. Kagota S; Tamashiro A; Yamaguchi Y; Nakamura K; Kunitomo M J Pharmacol Exp Ther; 2002 Jul; 302(1):344-51. PubMed ID: 12065736 [TBL] [Abstract][Full Text] [Related]
38. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model. Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050 [TBL] [Abstract][Full Text] [Related]